Home / Resource Library / Long-term outcomes of venetoclax and ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma

Long-term outcomes of venetoclax and ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma

Results of a study investigating venetoclax with ibrutinib for treatment of relapsed MCL.